The goal of characterizing solid-tumor genomes with nothing more than a blood sample is now within reach.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
Molecular Cancer Open Access 21 January 2023
-
Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma
BMC Cancer Open Access 01 October 2020
-
Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal
Journal of Translational Medicine Open Access 17 June 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pantel, K. & Alix-Panabieres, C. Cancer Res. 73, 6384–6388 (2013).
Lohr, J.G. et al. Nat. Biotechnol. 32, 479–484 (2014).
Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra224 (2014).
Im, H. et al. Nat. Biotechnol. 32, 488–493 (2014).
Lawrence, M.S. et al. Nature 505, 495–501 (2014).
Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012).
Hou, Y. et al. Cell 148, 873–885 (2012).
Pantel, K., Brakenhoff, R.H. & Brandt, B. Nat. Rev. Cancer 8, 329–340 (2008).
Wan, L., Pantel, K. & Kang, Y. Nat. Med. 19, 1450–1464 (2013).
Heitzer, E. et al. Cancer Res. 73, 2965–2975 (2013).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Speicher, M., Pantel, K. Tumor signatures in the blood. Nat Biotechnol 32, 441–443 (2014). https://doi.org/10.1038/nbt.2897
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2897
This article is cited by
-
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
Molecular Cancer (2023)
-
Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects
Analytical and Bioanalytical Chemistry (2023)
-
Expression and DNA methylation profiles of EZH2-target genes in plasma exosomes and matched primary tumor tissues of the patients with diffuse large B-cell lymphoma
Clinical and Translational Oncology (2021)
-
Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma
BMC Cancer (2020)
-
Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal
Journal of Translational Medicine (2020)